Business Context and Reporting Period
Envoy Medical, Inc. (Nasdaq: COCH, COCHW) filed this Form 8-K on October 23, 2025, reporting a significant corporate governance event regarding its continued listing status on The Nasdaq Stock Market. The Company is an emerging growth company incorporated in Delaware.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on regulatory compliance status.
Material Changes
The primary material event is the resolution of a listing deficiency:
- Exception Granted: The Nasdaq Hearings Panel granted the Company an exception to demonstrate compliance with the $35 million Market Value of Listed Securities (MVLS) requirement (Nasdaq Listing Rule 5550(b)(2)).
- Compliance Deadline: The Company has until February 23, 2026, to regain compliance with the MVLS requirement.
- Background: The Company initially received a non-compliance notice on February 25, 2025, and failed to regain compliance within the standard 180-day cure period, leading to a hearing on October 2, 2025.
Outlook, Risks, and Management Commentary
Management Obligations: Under the terms of the Exception, the Company must provide the Nasdaq Hearings Panel with prompt notification of any significant events that may call into question its ability to satisfy the terms of the Exception.
Risks: The primary risk is the failure to meet the $35 million MVLS requirement by the February 23, 2026 deadline, which could result in delisting.
Unusual Items: None reported in this filing.
Investor Verification Checklist
- Verify the current market capitalization and share price to assess the feasibility of meeting the $35 million MVLS requirement by February 23, 2026.
- Monitor future 8-K filings for any "significant events" that the Company is required to report to the Nasdaq Panel under the Exception terms.
- Review the attached press release (Exhibit 99.1) for additional details on the Company's strategy to regain compliance.